Clinical Trial Update: Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003 [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of LIB003 in Hypercholesterolemia has completed. The trial was sponsored by LIB Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• LIB003

Snippet

Sponsor: LIB Therapeutics LLC | Conditions: Hypercholesterolemia | Phase 1 | Status: COMPLETED